{"name":"BioMarck Pharmaceuticals, Ltd.","slug":"biomarck-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BIO-11006 Inhalation Solution","genericName":"BIO-11006 Inhalation Solution","slug":"bio-11006-inhalation-solution","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BIO-11006 Inhalation Solution","genericName":"BIO-11006 Inhalation Solution","slug":"bio-11006-inhalation-solution","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNc1BSX1Vlb2xnUFVQLVpybnV0NldIQjZ1MExoX0RvTnRiMk9SU2xxeHBMVFMtd2EwTGxMTFhLa1Z5SVE1blppZjl4akQ2TlM5TVJmUmhJZV9kNmNpb09aVktqTE5vNTYxTFU5ZFpfVEQwc1N3eGN1YmVfVzVNWndhdjV4Ql82OXkwcnM2Qk1oWnVCdnIxV19uT1NYYzJ2dmhuUUd4TVljV1dDc0tSUlpqY0lyQk5oS2QzbFhyTWtwYXdITlJsRlJ1WFVCUmgyYU5xM1NFRE1nbGhFV1QtdzZVaDk0WlhiY2pUaFJZdmlHUDdSZ2RVNlVxeDhxYjlsZmxVNWNoaVdLaGpqdUk?oc=5","date":"2024-11-20","type":"pipeline","source":"PR Newswire","summary":"Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveInsight - PR Newswire","headline":"Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxObHRZbW5qbUhROVktVlZwYWNoYjRlVEtjME5JVzlWRzFqdlhpLXljMk5BWmRqNXZXbmhpTFpHWlR1QmYtbm5WVEJwQ0xfaVFrTnhvRGNNMnkteHpmRGVvTTNYSnRjY3ZFa0QtLXVSX1Q3VFJLOUFtUTRQTTdhX3ZfWHJ5ZlIwRldIT1VpaER0ZndiekZ0akJvOFZPNFlfb21fU1pFQ0pwNVJqdXRNZVRKTDVCQnZJXy1VVWFTQlE0S0ZzVjRKdW1IVWx3WTdJSERaNzk3alM3Zk53Mmd5QWpRcEQzcEdJWVJ0RktSalJXUGRtZk9reGVTbnhkMmo0SlE?oc=5","date":"2024-08-07","type":"pipeline","source":"globenewswire.com","summary":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight - globenewswire.com","headline":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPeWU1NS05X3A1eWRwZnItNWlHdVlVeXd1Sk40NTNUQWNudFBWRFA2THVRZU54ZlFya1dUeDhaYUZKdHVNdXlWNG1pb1hhRE5UcHZnTGNuT195QkpJVzVxekhhWDcyRW9VOGVBRjJBakg4WFRkdy0yUnFXTDdMcDVla2E3a0tEbUNMUW85UDZneUF4V2dRVlkzOUdTc0lTT28yRmZEOHhWWnIxLTU2RFEwUW5XQklNMlVYbWxnbXFrZFh0clJ0a1FiejF3dFctWXk0dXlNeTE4TGxhSEswckw3eDZ3SGlfUXl0?oc=5","date":"2020-02-18","type":"pipeline","source":"24-7 Press Release Newswire","summary":"Indu Parikh Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who - 24-7 Press Release Newswire","headline":"Indu Parikh Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who - 24-7 Press Releas","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}